Operant Conditioning for ACL Injury
Trial Summary
What is the purpose of this trial?
The purpose of this study is to examine if thigh muscle weakness and the lack of muscle activation that accompanies ACL injury can be improved through a form of mental coaching and encouragement, known as operant conditioning.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are taking drugs that reduce the seizure threshold, you may not be eligible to participate.
What data supports the effectiveness of the treatment Operant Conditioning for ACL Injury?
Research suggests that incorporating motor learning principles, which are part of operant conditioning, can enhance neuroplasticity (the brain's ability to reorganize itself) and improve functional performance after ACL injury. This approach may help reduce the risk of a second ACL injury and early onset of osteoarthritis by targeting changes in neural networks.12345
Is operant conditioning generally safe for humans?
Operant conditioning has been studied in various contexts, including pain modulation and motor performance, and while it can influence pain perception, there is no specific mention of safety concerns in the studies reviewed. However, some studies suggest that operant conditioning can induce changes in pain perception, such as increased sensitivity, which should be considered when evaluating its safety.678910
How is the treatment Operant Conditioning for ACL Injury different from other treatments?
Operant Conditioning for ACL Injury is unique because it uses a learning-based approach to enhance the brain's ability to control muscles by increasing the activity of specific pathways in the nervous system, which can improve movement and recovery. This method focuses on training the brain and muscles to work better together, unlike traditional treatments that might focus more on physical therapy or medication.711121314
Research Team
Chandramouli Krishnan, PhD
Principal Investigator
Assistant Professor
Eligibility Criteria
This trial is for individuals aged 18-45 who have had an ACL rupture and subsequent reconstructive surgery. Participants must be willing to follow the study's procedures. Those pregnant, with previous major knee surgeries, on certain drugs, with fainting spells, uncontrolled diabetes or hypertension, ear/heart devices, recurrent headaches, seizures or recent significant knee injuries cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive operant conditioning training and single pulse transcranial magnetic stimulation 2-3 times a week
Mid-point Evaluation
Assessment of quadriceps strength and voluntary activation using isokinetic dynamometer and electrical superimposition technique
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Operant Conditioning
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Center of Neuromodulation for Rehabilitation
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Medical University of South Carolina
Collaborator
National Center of Neuromodulation for Rehabilitation
Collaborator